Bibliographic information
GuidelineAntiretroviral therapy of HIV infection in infants and children: towards universal access: recommendations for a public health approach 2010 revision
Year of Publication2010
Issuing InstitutionWHO
Recommendation
New
The preferred first-line ARV regimen for children more than 3 years of age who are taking a rifampicin-containing regimen for TB is 2 nucleoside reverse transcriptase inhibitor (NRTI) + efavirenz (EFV).
Recommended in favor
Conditional
Certainty of evidence
Very low